draflazine has been researched along with Osteogenic Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heitman, LH; IJzerman, AP; Vlachodimou, A | 1 |
1 other study(ies) available for draflazine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.
Topics: Cell Line, Tumor; Equilibrative Nucleoside Transporter 1; Humans; Ligands; Membrane Transport Proteins; Osteosarcoma; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Signal Transduction | 2019 |